Back
HFA Premium Access

Tolerance and clinical response to SGL2 inhibitors in Fabry disease

Session: ePosters in chronic heart failure - pharmacotherapy 3
Topic: Pharmacotherapy
Speaker: Doctor I. Mattig (Berlin, DE)
Event: Heart Failure 2024

Congress Presentation

Add to my library

Like

About the speaker

Doctor Isabel Mattig

Charité - University Medicine Berlin, Berlin (Germany)
1 presentation
0 follower

4 more presentations in this session

The role of intermittent levosimendan infusions in patients with advanced heart failure: is it enough?

Speaker: Doctor I. Campos (Penafiel, PT)

Access
Abstract
Slides
Video
Like
Thumbnail

Predictors of complete evidence-based treatment implementation at hospital discharge of acute heart failure with reduced LVEF in a real-world population

Speaker: Doctor S. Ruiz Bustillo (Barcelona, ES)

Access
Abstract
Slides
Video
Like
Thumbnail

12-Month effect of Tafamidis on the clinical progression of cardiac amyloidosis in a single centre cohort

Speaker: Doctor R. Carvalheiro (Lisbon, PT)

Access
Abstract
Slides
Video
Like
Thumbnail

Optimizing heart failure management: impact of quadruple therapy initiation at discharge following decompensation events in patients with reduced ejection fraction

Speaker: Doctor C. Gregorio (Lisbon, PT)

Access
Abstract
Slides
Video
Like
Thumbnail

Access the full session

ePosters in chronic heart failure - pharmacotherapy 3

Speakers: Doctor I. Mattig, Doctor I. Campos, Doctor S. Ruiz Bustillo, Doctor R. Carvalheiro, Doctor C. Gregorio
Access
Like
Thumbnail

About the event

Image

Heart Failure 2024

11 May - 14 May 2024

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources